| Autor: |
Poluektov MG; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Akarachkova ES; LLC International society «Stress under control», Moscow, Russia., Dovgan EV; Smolensk Regional Clinical Hospital, Smolensk, Russia., Kotova OV; LLC International society «Stress under control», Moscow, Russia.; Peoples' Friendship University of Russia, Moscow, Russia., Demidova TY; Pirogov Russian National Research Medical University, Moscow, Russia., Klimenko AA; Pirogov Russian National Research Medical University, Moscow, Russia., Kokorin VA; Pirogov Russian National Research Medical University, Moscow, Russia., Ostroumova OD; Russian Medical Academy of Continuous Professional Education, Moscow, Russia., Ostroumova TM; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. |
| Abstrakt: |
Insomnia is a serious and widespread public health problem, but is often undetected and patients do not receive needed treatment. Insomnia is often comorbid with other diseases and conditions, such as arterial hypertension, type 2 diabetes mellitus, pain syndromes, anxiety and depressive disorders, etc. A separate problem is drug-induced insomnia, when patients develop symptoms due to other diseases treatments. Insomnia has a negative effect on the prognosis of comorbid diseases, including an increased risk of death, more severe disease, and decreased quality of life. The presence of sleep disorders makes it difficult to effectively treat the underlying disease, so clinical guidelines draft for the evaluation and treatment of insomnia in multimorbid patients is proposed. Diagnostic methods are reviewed and recommendations are given for the treatment of acute and chronic insomnia and features of the treatment of insomnia in multimorbid patients. A clinical algorithm has been proposed to determine treatment tactics in multimorbid patients. |
